Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Share News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.00
Bid: 6.75
Ask: 7.25
Change: -0.25 (-3.45%)
Spread: 0.50 (7.407%)
Open: 7.50
High: 7.25
Low: 7.00
Prev. Close: 7.25
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Persimmon Leads Housebuilders Higher

Tue, 21st Aug 2018 10:44

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Persimmon, up 1.3%. The housebuilder said it continued to deliver on its long-term strategy after recording a rise in first half profit and revenue. For the six months to the end of June, pretax profit totaled GBP516.5 million, up 13% from GBP457.4 million the year before, as revenue grew 5% to GBP1.84 billion from GBP1.75 billion. Persimmon said it sold 8,402 homes during the period, up from 7,794 the prior year, with the average selling price of those homes standing at GBP215,813, up 1.2% from GBP213,262. Fellow housebuilders Berkeley Group, Barratt Developments and Taylor Wimpey were up 0.8%, 0.7% and 0.5% respectively. WM Morrison Supermarkets, up 0.9% and Ocado, up 0.5%. Morrisons regained the position of fastest growing - which it had lost to Asda last month - with sales up 2.7% and market share flat at 10.4% according to data from Kantar Worldpanel. Ocado saw sales up 8.5%, as it increased its market share to 1.2% from 1.1% recorded in the year ago period. Kantar - reporting market share figures for the 12 weeks to August 12 - said branded products sales increased 3.9%, overtaking the total growth of supermarket-owned products for the first time since May 2015.----------FTSE 100 - LOSERS----------BHP Billiton, down 1.3%. The Anglo-Australian miner paid out to shareholders above its policy level, with annual profit rising though short of consensus. The total dividend for BHP's financial year was 118 cents, far higher than the 83 cents paid out a year earlier and above analyst consensus of a 116 cents return. BHP's pretax profit rose to USD14.75 billion from USD11.14 billion the prior year, while underlying earnings before interest, tax, depreciation, and amortisation was up 20% to USD23.18 billion. This excludes US shale operations, since sold off to BP, and falls short of analyst consensus of USD24.31 billion underlying Ebitda. Including US shale, the figure was USD24.11 billion. ----------FTSE 250 - WINNERS----------John Wood Group, up 6.5%. The oilfield services company swung to a loss in the first half of 2018 due to its purchase of Amec Foster Wheeler, in spite of strong revenue growth. The company swung to a pretax loss for the six months to the end of June on a proforma basis of USD25.3 million from a profit of USD13.5 million the year before, due to a one-off cost of USD101.1 million. The loss stemmed from bank fees related to the GBP2.20 billion acquisition of peer Amec Foster Wheeler, which completed in October. However, on an underlying basis, pretax profit rose to USD82.0 million from USD64.2 million. John Wood's revenue saw double digit growth, rising by 13% to USD5.38 billion from USD4.74 billion on a proforma basis the year before, due to growth in the company's Asset Solutions Business with increased capital projects activity.Aggreko, up 5.1%. HSBC upgraded the temporary power generator supplier to Buy from Hold. ----------OTHER MAIN MARKET AND AIM - WINNERS----------IXICO, up 16%. The data science company said it expects 24% jump in annual revenue, ahead of market expectations. For the year ending September 30, the data science company said it now expects revenue to be "at least" GBP5.1 million, up from GBP4.1 million a year ago, reflecting contract wins in the period. "The board expects that this will result in a reduced operating loss for the year," the company added. Looking further ahead, the company said it it confident in meeting market expectations for the year ending Septmebr 2019, as it "continues to invest in its commercially led growth strategy on the path to profitability".Tracsis, up 8.8%. The transport industry software and technology company said it expects annual revenue "ahead of market expectations" after experiencing positive momentum in all parts of the group. For the year to July 31, the company said it expects revenue at GBP40 million, up 16% from GBP34.5 million a year ago. The company added that it expects earnings before interest, taxes, depreciation and amortisation and adjusted profit to be both ahead of market expectations and ahead of the previous year, which had come in at GBP8.5 million and GBP7.7 million respectively.----------OTHER MAIN MARKET AND AIM - LOSERS----------Panthera Resources, down 25%. The gold exploration and development company noted that the government of Rajasthan has rejected the prospecting licence application made for the Bhukia joint venture in India by partner Metal Mines India. The government rejected the application due to finding the reconnaissance permit granted to Metal Mines null and void as the licence application was filed under the name Metal Mining India Ltd but the permit given to Metal Mining India Pvt Ltd. Other reasons for the rejection was a restriction in place for grant in Tibal Areas under a government order in 2000, and because the Geological Survey of India had reserved some of the land, and has expressed intentions to carry out G-2 level exploration. Panthera Resources said its joint venture has an very strong base to launch a legal challenge against the Rajasthan government to deny his rights.----------
More News
7 Dec 2021 15:41

Ixico sees "significant growth" despite notable headwinds; shares up

Ixico sees "significant growth" despite notable headwinds; shares up

Read more
30 Nov 2021 16:26

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
1 Nov 2021 15:43

Ixico tapped for another phase-3 clinical trial

(Sharecast News) - Artificial intelligence (AI) data analytics company Ixico has been selected by its largest pharmaceutical client to provide neuroimaging services for a new phase 3 clinical trial focussed on a demyelinating disorder, it announced on Monday.

Read more
18 Oct 2021 09:33

Ixico FY revenues projected to beat expectations

(Sharecast News) - AI data analytics company Ixico said on Monday that full-year revenues were projected to have beat expectations despite falling shy of prior year comparatives.

Read more
22 Sep 2021 11:19

Ixico secures new contract valued at more than $750,000

(Sharecast News) - AI data analytics firm Ixico has secured a new contract valued at more than $750,000 over two years for advanced neuroimaging solutions.

Read more
8 Sep 2021 12:47

Ixico awarded phase 1 clinical trial contract

(Sharecast News) - Neuroscience artificial intelligence (AI) company Ixico has been awarded a contract by a new biopharmaceutical client to support its phase 1 multiple system atrophy clinical trial, it announced on Wednesday.

Read more
6 Aug 2021 14:53

Ixico confident as full-year revenue, earnings decline

(Sharecast News) - Data analytics company Ixico updated the market on its trading on Friday, confirming that despite a "challenging" business environment, it expected to deliver £8.7m in revenues for the 2021 financial year.

Read more
26 Apr 2021 09:06

Ixico H1 revenues grow despite Covid-19 impacts on clinical development sector

(Sharecast News) - Clinical research firm Ixico said on Monday that revenues were expected to have improved in the six months ended 31 March, despite the impacts of the Covid-19 pandemic on the clinical development sector.

Read more
15 Mar 2021 10:13

Ixico strikes collaboration deal with Microsoft

(Sharecast News) - Data analytics company Ixico said on Monday that it had struck a collaboration agreement with tech giant Microsoft to develop its artificial intelligence analytics platform for the global pharmaceutical industry.

Read more
10 Mar 2021 14:30

Ixico selected for Alzheimer's clinical trial

(Sharecast News) - Neuroscience artificial intelligence (AI) analytics company Ixico has been selected by a current mid-sized biopharmaceutical client to support a phase 2 Alzheimer's disease clinical trial, it announced on Wednesday.

Read more
24 Dec 2020 12:20

Ixico awarded ?3.4m contract by existing client

(Sharecast News) - Artificial intelligence (AI) data analytics company Ixico has been awarded a £3.4m contract to run over 4.5 years by an existing client, it announced on Thursday, for a spinocerebellar ataxia type-3 (SCA3) trial.

Read more
8 Dec 2020 09:26

Ixico to provide neuroimaging solutions to unnamed global pharmaceutical group

(Sharecast News) - Data analytics firm Ixico has secured a contract for neuroimaging solutions with a "large global pharmaceutical company".

Read more
27 Nov 2020 12:09

Ixico executes contract for Huntington's disease clinical trial

(Sharecast News) - Neuroscience data analytics company Ixico has executed a contract to provide neuroimaging services that would support a phase 1b and 2 clinical trial for Huntington's disease, it announced on Friday.

Read more
3 Nov 2020 10:43

Ixico wins new contracts in Alzheimer's clinical trials

(Sharecast News) - Neuroscience data analytics company Ixico has secured new contracts in Alzheimer's disease (AD) clinical trials, it announced on Tuesday.

Read more
22 Oct 2020 15:00

Ixico secures two Huntington's disease clinical trial contracts

(Sharecast News) - Neuroscience data analytics company Ixico has secured new contracts in Huntington's disease clinical trials.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.